Cargando…
Target Product Profiles for medical tests: a systematic review of current methods
BACKGROUND: A Target Product Profile (TPP) outlines the necessary characteristics of an innovative product to address an unmet clinical need. TPPs could be used to better guide manufacturers in the development of ‘fit for purpose’ tests, thus increasing the likelihood that novel tests will progress...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212678/ https://www.ncbi.nlm.nih.gov/pubmed/32389127 http://dx.doi.org/10.1186/s12916-020-01582-1 |
_version_ | 1783531658131013632 |
---|---|
author | Cocco, Paola Ayaz-Shah, Anam Messenger, Michael Paul West, Robert Michael Shinkins, Bethany |
author_facet | Cocco, Paola Ayaz-Shah, Anam Messenger, Michael Paul West, Robert Michael Shinkins, Bethany |
author_sort | Cocco, Paola |
collection | PubMed |
description | BACKGROUND: A Target Product Profile (TPP) outlines the necessary characteristics of an innovative product to address an unmet clinical need. TPPs could be used to better guide manufacturers in the development of ‘fit for purpose’ tests, thus increasing the likelihood that novel tests will progress from bench to bedside. However, there is currently no guidance on how to produce a TPP specifically for medical tests. METHODS: A systematic review was conducted to summarise the methods currently used to develop TPPs for medical tests, the sources used to inform these recommendations and the test characteristics for which targets are made. Database and website searches were conducted in November 2018. TPPs written in English for any medical test were included. Based on an existing framework, test characteristics were clustered into commonly recognised themes. RESULTS: Forty-four TPPs were identified, all of which focused on diagnostic tests for infectious diseases. Three core decision-making phases for developing TPPs were identified: scoping, drafting and consensus-building. Consultations with experts and the literature mostly informed the scoping and drafting of TPPs. All TPPs provided information on unmet clinical need and desirable analytical performance, and the majority specified clinical validity characteristics. Few TPPs described specifications for clinical utility, and none included cost-effectiveness. CONCLUSIONS: We have identified a commonly used framework that could be beneficial for anyone interested in drafting a TPP for a medical test. Currently, key outcomes such as utility and cost-effectiveness are largely overlooked within TPPs though and we foresee this as an area for further improvement. |
format | Online Article Text |
id | pubmed-7212678 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-72126782020-05-18 Target Product Profiles for medical tests: a systematic review of current methods Cocco, Paola Ayaz-Shah, Anam Messenger, Michael Paul West, Robert Michael Shinkins, Bethany BMC Med Research Article BACKGROUND: A Target Product Profile (TPP) outlines the necessary characteristics of an innovative product to address an unmet clinical need. TPPs could be used to better guide manufacturers in the development of ‘fit for purpose’ tests, thus increasing the likelihood that novel tests will progress from bench to bedside. However, there is currently no guidance on how to produce a TPP specifically for medical tests. METHODS: A systematic review was conducted to summarise the methods currently used to develop TPPs for medical tests, the sources used to inform these recommendations and the test characteristics for which targets are made. Database and website searches were conducted in November 2018. TPPs written in English for any medical test were included. Based on an existing framework, test characteristics were clustered into commonly recognised themes. RESULTS: Forty-four TPPs were identified, all of which focused on diagnostic tests for infectious diseases. Three core decision-making phases for developing TPPs were identified: scoping, drafting and consensus-building. Consultations with experts and the literature mostly informed the scoping and drafting of TPPs. All TPPs provided information on unmet clinical need and desirable analytical performance, and the majority specified clinical validity characteristics. Few TPPs described specifications for clinical utility, and none included cost-effectiveness. CONCLUSIONS: We have identified a commonly used framework that could be beneficial for anyone interested in drafting a TPP for a medical test. Currently, key outcomes such as utility and cost-effectiveness are largely overlooked within TPPs though and we foresee this as an area for further improvement. BioMed Central 2020-05-11 /pmc/articles/PMC7212678/ /pubmed/32389127 http://dx.doi.org/10.1186/s12916-020-01582-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Cocco, Paola Ayaz-Shah, Anam Messenger, Michael Paul West, Robert Michael Shinkins, Bethany Target Product Profiles for medical tests: a systematic review of current methods |
title | Target Product Profiles for medical tests: a systematic review of current methods |
title_full | Target Product Profiles for medical tests: a systematic review of current methods |
title_fullStr | Target Product Profiles for medical tests: a systematic review of current methods |
title_full_unstemmed | Target Product Profiles for medical tests: a systematic review of current methods |
title_short | Target Product Profiles for medical tests: a systematic review of current methods |
title_sort | target product profiles for medical tests: a systematic review of current methods |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212678/ https://www.ncbi.nlm.nih.gov/pubmed/32389127 http://dx.doi.org/10.1186/s12916-020-01582-1 |
work_keys_str_mv | AT coccopaola targetproductprofilesformedicaltestsasystematicreviewofcurrentmethods AT ayazshahanam targetproductprofilesformedicaltestsasystematicreviewofcurrentmethods AT messengermichaelpaul targetproductprofilesformedicaltestsasystematicreviewofcurrentmethods AT westrobertmichael targetproductprofilesformedicaltestsasystematicreviewofcurrentmethods AT shinkinsbethany targetproductprofilesformedicaltestsasystematicreviewofcurrentmethods |